Expertise in
8
conditions

Stefan Sleijfer

Rotterdam, ZH, NL 
Expertise in
8
conditions
Rotterdam, ZH, NL 

Overview

Stefan Sleijfer practices practicing medicine in Rotterdam, Netherlands.

Mr. Sleijfer is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Breast Cancer, Tissue Biopsy, and Hepatectomy.

He is actively involved in clinical research, co-authoring 363 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Rotterdam, ZH, Netherlands
Other Locations
GE 3015RO, Netherlands
Nijmegen, GE 6500HB, Netherlands
Zuideinde, OV, Netherlands
Amsterdam, NH, Netherlands
Utrecht, UT, Netherlands
Leiden, ZH, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

An International, Multicenter, Open-label, Randomized, Phase 3 Study of BLU-285 vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)
An International, Multicenter, Open-label, Randomized, Phase 3 Study of BLU-285 vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)
Enrollment Status: Completed
Publish Date: October 06, 2022
Intervention Type: Drug
Study Drugs: Avapritinib, Regorafenib
Study Phase: Phase 3

363 Total Publications

Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast Cancer.
Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast Cancer.
Journal: Diagnostics (Basel, Switzerland)
Published: February 06, 2026

Frequently Asked Questions about Stefan Sleijfer

Is Stefan Sleijfer a top-rated expert for Adult Soft Tissue Sarcoma?

MediFind is an objective health platform that identifies experts based on real-world data. Stefan Sleijfer is classified as an Distinguished expert for Adult Soft Tissue Sarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Stefan Sleijfer participate in research or clinical trials?

Yes. Stefan Sleijfer has published 363 articles and abstracts on conditions like Adult Soft Tissue Sarcoma. You can view a list of Stefan Sleijfer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Sleijfer's expertise for a condition
ConditionClose
    View All 27 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile